Technology has forever transformed the entire healthcare continuum and has ushered in new and revolutionary ways to ensure patient and consumer safety. It has also enabled organizations to achieve higher levels of insight, quality and efficiencies by driving down operational costs and rendering information in meaningful ways. Technology has weaved itself into safety operations by being a strategic element of worldwide pharmacovigilance (PV) systems, fundamentally altering the drug safety continuum. To enable transformation, one of the biggest challenges organizations face is how to effectively integrate the complexities of two seemingly separate functions, the technology know-how behind IT and the science behind Safety Operations. Companies that recognize the synergies of an integrated strategy and unified communication process will see greater success in managing the safety of their products, including proactive responses to problems and business priorities.
Learn how to reduce financial fraud and improve risks management. What are the most common risks for activities and business processes? How a SoD repository is commonly set up? Learn the top 3 SoD conflict types and how to implement a methodology in order to leverage your SAP governance.
Main points covered:
• How to reduce financial fraud and improve risks management
• What are the most common risks for activities and business processes?
• How a SoD repository is commonly set up?
• Learn the top 3 SoD conflict types
Presenter:
The webinar was presented by M. Roseau, director of business development for In Fidem, a Canadian company based in Montreal, Quebec.
Link of the recorded session published on YouTube: https://youtu.be/bRsiWx2NodA
McKesson Quality eMeasures™ calculates and submits meaningful use quality measures to the Centers for Medicare & Medicaid Services (CMS) and the states, providing an integrated approach to meeting reporting requirement. It is part of the McKesson Enterprise Intelligence portfolio of solutions.
Standards / Models for Setting Up a Robust TCoE - Maveric SystemsMaveric Systems
This presentation explores different building blocks for robust Testing Centers of Excellence (TCoE) along with standards / models that can be used for defining and implementing them.
A pre-UAT round that quantifies and qualifies the application under test for User Acceptance Testing (UAT) CFT is a strategy derived from our Risk Based Testing Framework. It includesTesting of Business Critical Functionalities across modules with emphasis on Go-live functionalities. It indicates what trouble may lie ahead in UAT and can cover about 20-30% of cases planned for UAT
In this presentation from IVT's Qualifying and Validating Cloud and Virtualized IT Infrastructures, Chris Wubbolt and John Patterson focus on current trends in cloud computing environments, including aspects of cloud computing and Software-as-a-Service (SaaS) providers that may be of interest to US Food and Drug Administration investigators during an FDA inspection. Important compliance related points to consider for software vendors as they shift to becoming SaaS providers are discussed. The presentation also reviews the pros and cons of cloud computing from a business and compliance perspective, including differences between traditional computing environments and private/public clouds. Examples of issues to consider when using cloud computing environments and SaaS providers are also discussed.
Learn how to reduce financial fraud and improve risks management. What are the most common risks for activities and business processes? How a SoD repository is commonly set up? Learn the top 3 SoD conflict types and how to implement a methodology in order to leverage your SAP governance.
Main points covered:
• How to reduce financial fraud and improve risks management
• What are the most common risks for activities and business processes?
• How a SoD repository is commonly set up?
• Learn the top 3 SoD conflict types
Presenter:
The webinar was presented by M. Roseau, director of business development for In Fidem, a Canadian company based in Montreal, Quebec.
Link of the recorded session published on YouTube: https://youtu.be/bRsiWx2NodA
McKesson Quality eMeasures™ calculates and submits meaningful use quality measures to the Centers for Medicare & Medicaid Services (CMS) and the states, providing an integrated approach to meeting reporting requirement. It is part of the McKesson Enterprise Intelligence portfolio of solutions.
Standards / Models for Setting Up a Robust TCoE - Maveric SystemsMaveric Systems
This presentation explores different building blocks for robust Testing Centers of Excellence (TCoE) along with standards / models that can be used for defining and implementing them.
A pre-UAT round that quantifies and qualifies the application under test for User Acceptance Testing (UAT) CFT is a strategy derived from our Risk Based Testing Framework. It includesTesting of Business Critical Functionalities across modules with emphasis on Go-live functionalities. It indicates what trouble may lie ahead in UAT and can cover about 20-30% of cases planned for UAT
In this presentation from IVT's Qualifying and Validating Cloud and Virtualized IT Infrastructures, Chris Wubbolt and John Patterson focus on current trends in cloud computing environments, including aspects of cloud computing and Software-as-a-Service (SaaS) providers that may be of interest to US Food and Drug Administration investigators during an FDA inspection. Important compliance related points to consider for software vendors as they shift to becoming SaaS providers are discussed. The presentation also reviews the pros and cons of cloud computing from a business and compliance perspective, including differences between traditional computing environments and private/public clouds. Examples of issues to consider when using cloud computing environments and SaaS providers are also discussed.
Enabling Proactive Quality Management Across Quality and ManufacturingVeeva Systems
Imagine a quality system that allows you to predict and address quality issues before they occur, increase efficiency through intelligent automation, and increase visibility and collaboration across the supply chain.
Today more than 450 pharma, biotech, medtech, and contract services have turned this vision into reality by redesigning their legacy processes and modernizing their quality infrastructure. Using industry best practices and a strong technology foundation, they standardized business processes across GxPs and unified and connected quality and manufacturing systems for speed and efficiency.
In this presentation, you will learn:
- How digital transformation enables companies to pursue quality excellence
- Opportunities to unify and streamline systems and processes
- Best practices from leading companies to enable proactive quality management
Our mission is to be a trusted provider of information technology services and solutions with core competencies in cybersecurity, information assurance, security engineering, risk management and security program and project management. Our proven methodologies and scalable solutions help our clients achieve maximum return on their investment.
How QEdge assist you to accelerate your ROI?SarjenSystems
QEdge provide you a single unified platform to streamline and automate your process, people, procedure and documentation for better transparency, control and performance.
Maveric is that committed assurance partner. Recognized as a leader in Europe, Middle East and Asia-Pacifi¬c, Maveric offers the full spectrum of Assurance services. We build quality into processes and programs, making their outcomes more predictable.
We also signifi¬cantly enhance functionality, usability and performance of applications our clients deploy.
We power technology-led business transformation programs for leading corporates in the Banking, Insurance and Telecom verticals through our leading-edge domain expertise, innovative productivity accelerators, superior knowledge of industry-standard solutions and relentless passion.
#ITLifecycleAssurance #Maveric
Subrata Guha, UL DQS Inc. IT Services Director, with more than 20 years of professional experience in the fields of IT Service Management, Software Engineering and Audit/Assessment of Quality Management Systems hosts a webinar that focuses on the transition to ISO IEC 27001:2013. This webinar includes:
- Highlights of the changes in ISO IEC 27001:2013
- Transition Strategy
- Q&A session
This webinar will provide valuable guidance to regulated companies in development and implementation of formal, defined, documented methods for analysis of product changes and when to file a new 510(k). Consideration of the U.S . FDA's current K-97-1 Memo / guidance document on "510(k) Device Modifications"
Test Process Consulting Services - Maveric SystemsMaveric Systems
At Maveric, we provide a complete portfolio of consulting services focused on enhancing your test capabilities, based on years of proven expertise in independent software testing for banks and financial institutions.
Today it is crucial for organizations to pay even greater attention on quality management as the
importance of this function in achieving ultimate business objectives is increasingly becoming
clearer. Importance of the Quality Management (QM) Function in achieving basic need by
ensuring compliance with Capability Maturity Model Integrated (CMMI) / International
Organization for Standardization (ISO) is a basic demand from business nowadays. However,
QM Function and its processes need to be made much more mature to prevent delivery outages
and to achieve business excellence through their review and auditing capability. Many
organizations now face challenges in determining the maturity of the QM group along with the
service offered by them and the right way to elevate the maturity of the same. The objective of
this whitepaper is to propose a new model –the Audit Maturity Model (AMM) which will
provide organizations with a measure of their maturity in quality management in the perspective
of auditing, along with recommendations for preventing delivery outage, and identifying risk to
achieve business excellence. This will enable organizations to assess QM maturity higher than
basic hygiene and will also help them to identify gaps and to take corrective actions for
achieving higher maturity levels. Hence the objective is to envisage a new auditing model as a
part of organisation quality management function which can be a guide for them to achieve
higher level of maturity and ultimately help to achieve delivery and business excellence.
5 Essential Steps for Successful Application Modernization StrategyJohnAdams514191
Explore the 5 Essential Steps for Successful Application Modernization Strategy in our latest blog post. We guide you through the process of modernizing your applications, from comprehensive assessment and planning to defining clear objectives and prioritizing applications. Discover various modernization approaches, learn best practices for execution and implementation, and understand the importance of continuous testing, monitoring, and improvement. This insightful guide is designed to help businesses enhance performance, user experience, and security in today's competitive digital landscape.
Read the full blog here in the link above.
Covance, in partnership with Oracle, offers a full-service, validated, private cloud, single-tenancy solution based on Argus technology, which enables faster and better safety decisions. This automated and integrated solution allows for easy scientific querying and analytics, which improves the quality and efficiency of safety operations. It also enhances compliance with E2B exchange for expedited and periodic reporting, allowing the organization to conduct global case processing, which can scale to tens of thousands of annual cases.
Revolutionizing CX_ How Digital Testing Leads the Way in Digital Transformati...kalichargn70th171
The digital transformation landscape has become a key topic of discussion
globally, especially in light of the ongoing economic downturn. The COVID-19
pandemic has only accelerated the need for businesses to keep pace with the
changing times, as they are driven to expedite their digital transformation
journey to ensure their continued operation, if not growth. The pandemic has
resulted in a shift in the traditional way of working, presenting new challenges
in implementing flexible work setups, remote client engagement, and
automated customer experiences.
Identifying and Navigating the Technology Lifecycle Stages in Your BusinessWIN Technology
Businesses are constantly changing. Sometimes the use of technology leads, and other times it lags. To attain targeted business value from your use of technology, you need to recognize your current situation. In this eBook, we outline a framework that is designed to help you recognize the characteristics of each stage of the technology lifecycle and prescribe pragmatic actions.
Enabling Proactive Quality Management Across Quality and ManufacturingVeeva Systems
Imagine a quality system that allows you to predict and address quality issues before they occur, increase efficiency through intelligent automation, and increase visibility and collaboration across the supply chain.
Today more than 450 pharma, biotech, medtech, and contract services have turned this vision into reality by redesigning their legacy processes and modernizing their quality infrastructure. Using industry best practices and a strong technology foundation, they standardized business processes across GxPs and unified and connected quality and manufacturing systems for speed and efficiency.
In this presentation, you will learn:
- How digital transformation enables companies to pursue quality excellence
- Opportunities to unify and streamline systems and processes
- Best practices from leading companies to enable proactive quality management
Our mission is to be a trusted provider of information technology services and solutions with core competencies in cybersecurity, information assurance, security engineering, risk management and security program and project management. Our proven methodologies and scalable solutions help our clients achieve maximum return on their investment.
How QEdge assist you to accelerate your ROI?SarjenSystems
QEdge provide you a single unified platform to streamline and automate your process, people, procedure and documentation for better transparency, control and performance.
Maveric is that committed assurance partner. Recognized as a leader in Europe, Middle East and Asia-Pacifi¬c, Maveric offers the full spectrum of Assurance services. We build quality into processes and programs, making their outcomes more predictable.
We also signifi¬cantly enhance functionality, usability and performance of applications our clients deploy.
We power technology-led business transformation programs for leading corporates in the Banking, Insurance and Telecom verticals through our leading-edge domain expertise, innovative productivity accelerators, superior knowledge of industry-standard solutions and relentless passion.
#ITLifecycleAssurance #Maveric
Subrata Guha, UL DQS Inc. IT Services Director, with more than 20 years of professional experience in the fields of IT Service Management, Software Engineering and Audit/Assessment of Quality Management Systems hosts a webinar that focuses on the transition to ISO IEC 27001:2013. This webinar includes:
- Highlights of the changes in ISO IEC 27001:2013
- Transition Strategy
- Q&A session
This webinar will provide valuable guidance to regulated companies in development and implementation of formal, defined, documented methods for analysis of product changes and when to file a new 510(k). Consideration of the U.S . FDA's current K-97-1 Memo / guidance document on "510(k) Device Modifications"
Test Process Consulting Services - Maveric SystemsMaveric Systems
At Maveric, we provide a complete portfolio of consulting services focused on enhancing your test capabilities, based on years of proven expertise in independent software testing for banks and financial institutions.
Today it is crucial for organizations to pay even greater attention on quality management as the
importance of this function in achieving ultimate business objectives is increasingly becoming
clearer. Importance of the Quality Management (QM) Function in achieving basic need by
ensuring compliance with Capability Maturity Model Integrated (CMMI) / International
Organization for Standardization (ISO) is a basic demand from business nowadays. However,
QM Function and its processes need to be made much more mature to prevent delivery outages
and to achieve business excellence through their review and auditing capability. Many
organizations now face challenges in determining the maturity of the QM group along with the
service offered by them and the right way to elevate the maturity of the same. The objective of
this whitepaper is to propose a new model –the Audit Maturity Model (AMM) which will
provide organizations with a measure of their maturity in quality management in the perspective
of auditing, along with recommendations for preventing delivery outage, and identifying risk to
achieve business excellence. This will enable organizations to assess QM maturity higher than
basic hygiene and will also help them to identify gaps and to take corrective actions for
achieving higher maturity levels. Hence the objective is to envisage a new auditing model as a
part of organisation quality management function which can be a guide for them to achieve
higher level of maturity and ultimately help to achieve delivery and business excellence.
5 Essential Steps for Successful Application Modernization StrategyJohnAdams514191
Explore the 5 Essential Steps for Successful Application Modernization Strategy in our latest blog post. We guide you through the process of modernizing your applications, from comprehensive assessment and planning to defining clear objectives and prioritizing applications. Discover various modernization approaches, learn best practices for execution and implementation, and understand the importance of continuous testing, monitoring, and improvement. This insightful guide is designed to help businesses enhance performance, user experience, and security in today's competitive digital landscape.
Read the full blog here in the link above.
Covance, in partnership with Oracle, offers a full-service, validated, private cloud, single-tenancy solution based on Argus technology, which enables faster and better safety decisions. This automated and integrated solution allows for easy scientific querying and analytics, which improves the quality and efficiency of safety operations. It also enhances compliance with E2B exchange for expedited and periodic reporting, allowing the organization to conduct global case processing, which can scale to tens of thousands of annual cases.
Revolutionizing CX_ How Digital Testing Leads the Way in Digital Transformati...kalichargn70th171
The digital transformation landscape has become a key topic of discussion
globally, especially in light of the ongoing economic downturn. The COVID-19
pandemic has only accelerated the need for businesses to keep pace with the
changing times, as they are driven to expedite their digital transformation
journey to ensure their continued operation, if not growth. The pandemic has
resulted in a shift in the traditional way of working, presenting new challenges
in implementing flexible work setups, remote client engagement, and
automated customer experiences.
Identifying and Navigating the Technology Lifecycle Stages in Your BusinessWIN Technology
Businesses are constantly changing. Sometimes the use of technology leads, and other times it lags. To attain targeted business value from your use of technology, you need to recognize your current situation. In this eBook, we outline a framework that is designed to help you recognize the characteristics of each stage of the technology lifecycle and prescribe pragmatic actions.
Application Modernization: Benefits, Challenges, and ApproachesCloudZenix LLC
Application modernization refers to the process of updating legacy applications to leverage modern technologies and meet evolving business needs. The benefits of modernization include increased agility, improved scalability, enhanced user experience, and reduced maintenance costs. However, challenges such as complex dependencies and legacy code can arise. Approaches like rehosting, re-platforming, and refactoring are commonly employed. To learn more about this topic, please visit our blog for comprehensive insights and practical advice on application modernization. https://cloudzenix.com/application-modernization-benefits-challenges-and-approaches/
TechSync founded by highly experienced professionals from IT industry. It provides end to end coverage from consulting to help Application development/maintenance/Testing strategy, to undertaking and executing the development activities for web based applications, online content/databases, and Software as well as application software environments. Committed to provide cost effective solutions and yet enhance time to market for our clients across verticals.
InfTo improve the quality of network performance through advanced communication
services and authorized users in equal access to state-of-the-art technology.
The Business Conundrum Facing Manufacturers
Manufacturing companies have traditionally
had an on-again-off-again relationship with
technology. However, the paradigm shift driven
by global manufacturing and distribution,
combined with rapid digital innovation, is
changing this equation.
Manufacturing companies have traditionally
had an on-again-off-again relationship with
technology. However, the paradigm shift driven
by global manufacturing and distribution,
combined with rapid digital innovation, is
changing this equation. Deloitte’s 2016 MHI
survey reveals that 83% of manufacturing
organizations believe investing in key digital
technologies such as IoT, robotics, Big
Data, cloud computing, etc. will be key to
competitive advantage in the near future.1
Genomics Solutions - Single Target to Whole Genome AnalysisCovance
With applied Genomics expertise, global co-location with Central Labs and solutions from biomarker discovery to CDx, our genomics solutions will help make your Precision Medicine drug development a reality.
Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...Covance
Getting a medical device to the patient takes more than good technology in today's environment. Compelling evidence and convincing value proposition matter. Competing priorities and differing stakeholder definitions of value are driving the need for creative, connected strategies to get the most from each step in the development process. And - as evidence is gathered - it should be used to inform and iterate regulatory, reimbursement and clinical post-market strategies.
Pharmacovigilance Risk Management for BiosimilarsCovance
This paper focuses on pharmacovigilance (PV) and risk management for biosimilars, the issues and challenges faced in monitoring their safety and possible solutions.
Cell & Gene Therapy post-approval solutions to reduce scientific, regulatory and commercial risks, and accelerate development wherever you are in your product's development.
Cell & Gene Therapy enterprise development solutions to reduce scientific, regulatory and commercial risks, and accelerate development wherever you are in your product's development.
Cell & Gene Therapy Clinical Development SolutionsCovance
Cell & Gene Therapy clinical development solutions to reduce scientific, regulatory and commercial risks, and accelerate development wherever you are in your product's development.
Inhalation Technology - The Future of Effective Respiratory TreatmentsCovance
Nonclinical development channels: technical strategies, formulations and devices. Conventionally, inhaled drugs have been used to deliver medicines targeted at the most widespread respiratory diseases - specifically, chronic obstructive pulmonary disease (COPD) and asthma.
The Challenges Associated with Evaluating the Cost Benefit of Gene Therapies ...Covance
Despite the growing availability of approved gene therapies, decision-makers face significant challenges when evaluating pricing and reimbursement of these novel therapeutics. From determining cost-benefit ratios, setting out patient access criteria and designing reimbursement plans, this white paper explores some of the complex aspects of value assessment for gene therapies, and discusses results from a survey of key decision-makers across Germany, Sweden and the UK responsible for making pricing and reimbursement decisions.
Environmental Risk Assessment for Pharmaceutical DrugsCovance
Understanding the Evaluation and Implications of Findings to the Regulatory Review of Human Medicines in the Environment. Pharmaceutical drugs are intended for the treatment of human disease, therefore the risk of their environmental exposure in clinical use needs to be evaluated. Environmental risk assessment (ERA) is part of the requirements when applying for marketing approval in many geographic regions throughout the world.
Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Par...Covance
Clinical trials are becoming increasingly complex and competitive, so attracting the best investigator sites to participate in a trial is a crucial step in meeting patient enrollment targets. Learn more about how investigator preference can help meet trial recruitment milestones.
Putting the Patient First: Launching a Comprehensive Patient-Centric ProgramCovance
Following a successful sponsor/CRO partnership in which Covance supported a large sponsor's reimbursement call center, a solid partnership had formed, founded on trust and a shared culture. The sponsor expanded this partnership with Covance with the desire to seamlessly transition another reimbursement support program from their current vendor. With the additional successful execution of this project, the sponsor selected Covance as their partner to consolidate all existing hub programs, build a tailored customer relationship management (CRM) tool and develop programs focused on the sponsor's specific needs and enhanced new therapeutic areas and markets.
Top 15 Pharma Gains an Edge in a Highly Competitive Specialty MarketCovance
Due to the complex nature of patient access and reimbursement process for specialty products, the client required a customized hub program to support multiple products, across several therapeutic areas. The unique intricacies of the initiative required a trusted strategic partner who could help advise, inform and support an innovative patient-centric program. In addition to possessing the right expertise and processes, the vendor needed to have a flexible technology platform that could be tailored to support the multiple brand requirements and deliver a seamless experience to various stakeholders including patients, healthcare professionals (HCPs) and specialty pharmacies.
Field Services: Providing On-Site, Field-Based Assistance to Support Customer...Covance
Ensuring access for patients can be complex and impacted by ever-changing factors that require an adaptable and responsive holistic solution to help provider and patients. Relying on a consultative approach, policy expertise and decades of experience, Covance Market Access deploys a variety of different filed-based teams that are tailored to meet your objectives and simplify access for your product.
Overcome the unique challenges of late-phase product development and generate the right data to support your products' objective. Products in late-phase development have complex needs and demands. Programs at this phase support new indications, value communication, adherence strategies, safety and efficacy and more.
Optimizing Each Patient's Product Access ExperienceCovance
Relying on a consultative approach, deep expertise and decades of experience, we work collaboratively with clients to deliver a successful product launch, program transition or program enhancement. Clients benefit from our market insights, strategic and unique approach and ability to continuously refine our processes.
Plant Metabolism Studies: Options for Plant CultivationCovance
Regulators across the world are concerned with ensuring that any residues left in or on a crop after application of a plant protection product (PPP), present minimal risk to the health of humans and animals. To achieve this, regulators need information on the identity of the residues and the levels of residues remaining in or on a crop, in order to assess dietary risk and set maximum residue levels (MRLs). The testing approaches used are harmonized across most countries worldwide, focusing on the Organization for Economic Co-operation and Development (OECD) Test Guidelines (TGs) for pesticide residue chemistry. This e-book paper focuses on the laboratory-based plant cultivation methods that underlie the success of OECD crop metabolism studies, namely TG 501 and 502.
K-REACH - How to Prepare for the K-REACH LegislationCovance
In 2015, South Korea introduced legislation designed to protect human health and the environment from the impact of chemicals. The two pieces of legislation introduced were the: Act on the Registration and Evaluation of Chemicals (K-REACH), which mandates the registration of all new and existing chemicals marketed or imported into South Korea at ≥1 metric ton per year, requiring detailed information on their likely hazard to human health and the environment and the Chemicals Control Act (CCA), which focuses on chemical reporting and chemical accident prevention.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
2. TRANSFORMING SAFETY OPERATIONS BY DELIVERING PROACTIVE INSIGHT, PROCESS
EXCELLENCE AND INNOVATION
Technology has forever transformed the entire healthcare continuum and has ushered in new and
revolutionary ways to ensure patient and consumer safety. It has also enabled organizations to achieve
higher levels of insight, quality and efficiencies by driving down operational costs and rendering
information in meaningful ways. Technology has weaved itself into safety operations by being a strategic
element of worldwide pharmacovigilance (PV) systems, fundamentally altering the drug safety continuum.
To enable transformation, one of the biggest challenges organizations face is how to effectively integrate
the complexities of two seemingly separate functions, the technology know-how behind IT and the science
behind Safety Operations. Companies that recognize the synergies of an integrated strategy and unified
communication process will see greater success in managing the safety of their products, including
proactive responses to problems and business priorities.
COVANCE ADVANTAGE
Increasing market and regulatory pressures have led companies to reassess their business operations and
how they impact productivity, operational costs, quality and audit readiness. Technology is an essential
enabler of these goals and provides a platform for innovation to support changing business needs.
Figure 1 – End-to-End Patient Safety Capabilities
3. As a leading global provider of Patient Safety services, Covance is uniquely positioned to combine our
safety expertise with our flexible and full life cycle Safety Technology Solutions. These solutions help
life science companies build Pharmacovigilance IT reference architectures, deploy signal detection
applications, and create enterprise portals for safety analytics. Our PV Technology and Automation
solutions help to transform PV operations and drive efficiencies across the PV continuum and our
safety cloud solution offers a full service validated private cloud single tenancy solution based on Argus
technology. Our Medical Call Center provides compliant medical information and safety services for
medical products. Additionally, we also provide solutions for business intelligence, analytics, querying
and reporting, validation and regulatory compliance. We offer companies a global model that ensures the
highest standards of compliance, quality and agility for reacting to change, while minimizing cost.
A FULL LIFE CYCLE APPROACH TO SAFETY TECHNOLOGY
By organizing our process methodologies across four stages, each of which is interconnected, we offer a
comprehensive solution that enables project productivity and predictable results.
Figure 2 – Safety Technology Life Cycle
PLANNING
Our planning services assess your existing technology environment and create innovative and practical
strategies that align with your priorities. Covance will plan the delivery of a tailored safety environment to
manage your technology priorities for the future while getting value out of your legacy investments. We
will explore business opportunities provided by new technology innovation and provide advice on how
technology can deliver you more business value.
As a safety database managed service (Figure 2) may make sense for your organization, Covance offers a
cohesive program that embraces our key competencies of technology, streamlined processes and tools,
people and quality. By unifying and standardizing on our best-in-class processes generated from our IT
Quality Management System, we maximize customer productivity and provide audit-ready compliance
with regulatory requirements.
4. Figure 3 – Covance Safety Database Managed Service
Covance projects are governed by our defined SOPs for project planning, while such processes are
designed to be flexible, scalable and capable of supporting the planning needs of a wide range of projects
and customer engagements. The planning phase provides clarity on project objectives, a phased work
breakdown structured approach, resources required, the level of effort anticipated and a project schedule.
DEPLOYING
Successful deployment of new Safety Technology Solutions is challenging for companies as they have a
wide organizational impact. Our four-phase deployment life cycle (Figure 3) follows a defined Software
Deployment Life Cycle (SDLC) based on the Rational Unified Process, providing clear direction and focus
on the path to be followed for each customer engagement.
Figure 4 – Covance Deployment Life Cycle
5. Each phase is defined and enables the project team to focus on a particular aspect of the project, with
specific milestones required. These milestones clearly indicate the progress of the project and ensure that
the project deliverables meet strict quality standards.
The goals of each phase are as follows:
▶ Inception – Understand the scope of the project and conduct detailed project planning
▶ Elaboration – Understand and document the specifications for the architecture as well as the
business requirements
▶ Construction – Build the architecture, install the application and qualify the hardware and software
▶ Transition – Define the verification phase where the functionality is tested and the user acceptance
testing is done
Covance also offers a preconfigured safety technology platform to reduce deployment time. This system
is achieved by prequalifying a safety technology application which reduces testing and documentation
time requirements.
MANAGING
Once your application solution moves to production, our Safety Technology Managed Service provides
measured service levels to ensure operational excellence. Our managed services include Service Support
(Platform, Application and User) and Service Delivery.
SERVICE SUPPORT
A well-thought-out application and user support strategy ensures that quality Technology Services are
delivered to the business and operations. Covance helps life sciences organizations manage changes
and problems in the safety technology infrastructure and ensure services are provided effectively and
with optimum quality. Application Support Services includes a comprehensive solution for managing
a variety of application service components depicted in Figure 4, offering customers a thorough and
dependable solution.
Figure 5 – Comprehensive Application Life Cycle Support Basic Framework
6. User Support Services provides information and problem solving services, ensuring that customers
maximize the value of the deployed safety technology solution. The user support processes include
incident tracking and severity escalation procedures to produce predictable results. These services engage
in typical ITIL (Information Technology Infrastructure Library) support as depicted below.
▶ Level 1 (Service Desk) first contact and resolves basic issues
▶ Level 2 provides application expertise and addresses most issues. When needed, L2 staff can draw
resources from an extended Support Expertise Framework, such as Oracle Database Administrators and
Microsoft Solutions Architects, to ensure timely resolution to more complex user issues.
▶ Level 3 engages expert support directly from the technology vendor. Typical support requirements
are ensuring product consulting (e.g., addressing software bug fixes, recommending software
enhancement requests etc.) troubleshooting, proactive problem identification and performance tuning.
SERVICE DELIVERY
Covance offers a management approach that allows for clear service definition, defined roles and
responsibilities, and expected standards for service quality, availability and timeliness. Our clients receive
the following reports as part of service delivery:
Monthly ticket analysis report
▶ Monthly security reports indicating attacks and phishing events
▶ Quarterly application uptime reports
▶ Quarterly application root cause analysis reports for Severity 1 (critical) incidents
▶ On-demand application root cause analysis for any non-Severity 1 incidents, upon customer request
In all Covance Managed Services for safety applications, customers also benefit from
best-in-class technology delivery in:
▶ Robust backups and disaster recovery with periodic disaster recovery drills support
▶ General backup and restore strategy
▶ Data center physical and logical security
▶ World-class data center infrastructure
ANALYZING
Data visibility and the ability to understand what your data is telling you are critical for your business
today. Technology is changing the way business operates, helping to streamline processes and ensuring
that information is shared, managed, and acted upon. However, with a significantly large volume of data
emerging from traditional sources as well as social media, the task of analyzing this data is far more
complex. Through data analytics services, Covance provides its customers with the ability to leverage this
data to extract meaningful insight for driving critical business decisions.
7. The data analysis services are broadly classified into three areas:
▶ Operational Dashboards: As part of Pharmacovigilance operations, it is critical to closely monitor the
operational parameters which in turn drive Compliance, Quality, Productivity and CAPA Management.
It is important to continuously analyze data to detect early warning indicators that could have a
bearing on business and compliance performance. Over the years, Covance has capitalized on its deep
pharmacovigilance domain expertise, combined with its technology capability, to devise multi-tiered
metrics and analysis techniques, which demonstrate consistent delivery levels far exceeding
operational goals.
▶ Continuous Process Improvement: With regulatory changes happening within the Life Sciences
industry, the bar is being raised. Given this increasing demand, it is imperative for the Life Sciences
industry, and service providers like Covance, to continuously improve on existing processes to deliver
better results. Through the application of data analysis and visualization techniques, far more insight,
that can drive operational improvement in existing processes, is possible. These process improvements
have a direct impact on Compliance, Quality and Productivity.
▶ Signal Detection: Identifying new potential risks and developing risk minimization action plans to
prevent or mitigate these risks is at the heart of all pharmacovigilance activities. Covance has the
knowledge, technology and expertise to qualitatively and quantitatively assess safety data, identify new
safety signals and develop risk management plans (RMPs).
BENEFITS TO CUSTOMERS
By combining our strength in the drug safety space with technology solutions and services, we offer a
global delivery model that ensures the highest standards of compliance, quality and agility in reacting to
change. Our solutions will help create the ideal environment for innovation and continuous improvement
across the entire drug product life cycle.
Figure 6 – Covance Advantage